JHS Svendgaard Labs Q1 FY27 Results: Net Profit ₹1.09 Crore
JHS Svendgaard Laboratories reported a net profit of ₹1.09 crore for the quarter ended June 30, 2026. This marks a significant improvement from a net loss of ₹3.57 crore in the corresponding quarter of the previous year. Total income for the quarter was ₹30.47 crore.
The improvement in financial results, moving from loss to profit, is a material development for the company, impacting investor sentiment and potentially its stock performance.
The company has reported a positive shift from a net loss to a net profit, indicating an improved financial performance.
JHS Svendgaard Laboratories Limited announced its Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026. The Board of Directors approved these results during their meeting held on August 11, 2026.
The company reported a net profit of ₹1.09 crore for the quarter ended June 30, 2026, compared to a net loss of ₹3.57 crore in the same quarter last year (ended June 30, 2025). The total income for the quarter stood at ₹30.47 crore.
The Board meeting commenced at 02:30 P.M. and concluded at 3:35 P.M. These financial results will also be available on the company's website, www.svendgaard.com.
What to do with a filing like this
JHS Svendgaard Laboratories Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by JHS Svendgaard Laboratories Limited. Read the original for the full detail.